Details

Autor(en) / Beteiligte

• Marot, Stéphane
• Malet, Isabelle
• Leducq, Valentin
• Abdi, Basma
• Teyssou, Elisa
• Soulie, Cathia
• Wirden, Marc
• Rodriguez, Christophe
• Fourati, Slim
• Pawlotsky, Jean-Michel
• Boutolleau, David
• Burrel, Sonia
• Calvez, Vincent
• Marcelin, Anne-Geneviève
• Jary, Aude

Titel

Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare Workers

Ist Teil von

• Clinical infectious diseases, 2022-03, Vol.74 (4), p.707-710

Ort / Verlag

US: Oxford University Press

Erscheinungsjahr

2022

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract There are concerns about neutralizing antibodies’ (NAbs’) potency against severe acute respiratory syndrome coronavirus 2 variants. Despite decreased NAb titers elicited by BNT162b2 vaccine against VOC202012/01 and 501Y.V2 strains, 28/29 healthcare workers (HCWs) had an NAb titer ≥1:10. In contrast, 6 months after coronavirus disease 2019 mild forms, only 9/15 (60%) of HCWs displayed detectable NAbs against 501Y.V2 strain.